NCT02092948 Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02080650 Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) Status COMPLETED Phase NA
NCT02080260 A Study of Regorafenib in Advanced Pancreatic Cancer Patients Status COMPLETED Phase PHASE2
NCT02079623 Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer Status COMPLETED Phase N/A
NCT02079285 Prospective Evaluation of Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy (EUS-FNAB) in the Absence of Rapid Onsite Evaluation Status COMPLETED Phase N/A
NCT02055313 Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival Status COMPLETED Phase N/A
NCT02050178 Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02047500 Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT02042859 Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer Status UNKNOWN Phase PHASE1
NCT02042378 A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation Status COMPLETED Phase PHASE2
NCT02024997 Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study Status COMPLETED Phase EARLY_PHASE1
NCT02024633 Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer Status UNKNOWN Phase PHASE1
NCT02022033 BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial Status COMPLETED Phase PHASE2
NCT02021500 A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046. Status COMPLETED Phase N/A
NCT02020252 Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials Status COMPLETED Phase N/A
NCT02005315 A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer Status COMPLETED Phase PHASE1